Both T2DM and new-onset hyperglycemia groups demonstrated higher levels of inflammatory markers, namely white blood cell counts (WBC), C-reactive protein (CRP), D-dimer, and interleukin-6, except for the plasma fibrinogen concentration. The gene discussed is CRP; the disease is type 2 diabetes mellitus.